• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Journal of Gastroenterology

    Journal of Gastroenterology

    JournalISSN 0944-1174eISSN 1435-5922中科院 医学 1区

    年发文量

    研究主题

    论文(10156)

    排序
    1NewModeling Intestinal Fibrosis in Inflammatory Bowel Disease: Translational Animal Models and Ex Vivo Platforms
    Rong Yan, Armand Ghozati, Haiming Chen, Kalyan Kumar Pasunooti, Waliul Islam,Ling Li,Florin M. Selaru

    Intestinal fibrosis is a common and debilitating complication of inflammatory bowel disease (IBD), particularly Crohn's disease (CD). Fibrotic remodeling can also occur in ulcerative colitis (UC). Despite its clinical significance, there are currently no approved antifibrotic therapies, largely due to an incomplete understanding of the fibrogenic mechanisms and a lack of effective translational models. In this review, we examine several categories of animal models, including chemical-induced, microbial/biologic, immune cell-mediated, mechanical damage repair, genetically susceptible and cytokine-driven, and innovative models such as radiation-induced and organoid models. We evaluate the utility of these models in recapitulating key features of fibrotic IBD, including ECM remodeling, fibroblast activation, chronic inflammation, tissue stiffening, muscularis propria remodeling, and—in selected systems—fixed luminal narrowing/stricture. By outlining the advantages and limitations of each model, we aim to provide researchers with a practical, application-oriented framework that links each model to its optimal research use, thereby supporting the development of targeted, pathophysiologically-driven therapeutic strategies for IBD-associated fibrosis and fibrostenosis.

    2026
    引用
    AI阅读
    加入学术空间
    2NewSalvage Esophagectomy Versus Photodynamic Therapy for Localized Residual or Recurrent Esophageal Squamous Cell Carcinoma after Definitive Chemoradiotherapy or Radiotherapy: a Single-Center Comparative Study
    Naoto Ujiie,Chiaki Sato,Yusuke Taniyama,Hiroshi Okamoto,Yohei Ozawa,Hirotaka Ishida,Michiaki Unno,Takashi Kamei

    Salvage esophagectomy is considered the standard curative treatment for localized residual or recurrent esophageal cancer after definitive chemoradiotherapy (CRT), but it is associated with substantial morbidity. Photodynamic therapy (PDT) has emerged as a less invasive alternative. We compared the outcomes of salvage esophagectomy and PDT for localized residual or recurrent esophageal squamous cell carcinoma (ESCC) after definitive CRT or radiotherapy (RT). We retrospectively reviewed 91 patients with cT1–2N0M0 residual or recurrent ESCC after definitive CRT or RT who underwent salvage esophagectomy (n = 33) or PDT (n = 58) at a single institution. Overall survival (OS), disease-specific survival (DSS), and treatment-related outcomes were evaluated. Patients treated with PDT were significantly older and had a higher comorbidity burden than those undergoing salvage esophagectomy. Salvage esophagectomy achieved an R0 resection rate of 94.0

    2026
    引用
    AI阅读
    加入学术空间
    3NewErythrocyte Phosphatidylserine Externalization Shows Greater Discriminatory Performance Than Red Cell Distribution Width for Early Recurrence or Progression in Hepatocellular Carcinoma
    Maoqing Tan, Wei Dai,Danni Cai, Yilin Shi, Junsheng Lin, Jun Huang,Jingru Liu,Xinai Liao,Dongliang Li,Huifang Huang

    Red cell distribution width (RDW) is associated with adverse outcomes in hepatocellular carcinoma (HCC), but whether this association reflects an HCC-associated erythrocyte injury phenotype remains unclear. We investigated whether phosphatidylserine (PS) externalization identifies an HCC-associated erythrocyte injury phenotype and is associated with tumor burden and early recurrence or progression. This prospective two-center clinical study included 97 patients with newly diagnosed HCC, 30 healthy donors, 13 patients with chronic hepatitis B, and 17 patients with HBV-related cirrhosis as disease controls. Erythrocyte injury phenotypes were characterized by flow cytometry, metabolomics, and proteomics. Findings were examined in orthotopic HCC mouse models and erythrocyte-HCC co-culture systems. PS externalization was elevated in patients with HCC and correlated with tumor diameter, multiplicity, metastasis, and Barcelona Clinic Liver Cancer stage. HCC also showed higher PS levels than chronic hepatitis B and HBV-related cirrhosis controls. Higher PS externalization remained independently associated with early recurrence or progression within 6 months after adjustment for maximum tumor diameter, tumor number, and lymph-node and/or distant metastasis (OR = 1.382; 95

    2026
    引用
    AI阅读
    加入学术空间
    4NewColumnar-lined Esophagus Measuring Less Than 1 Cm As a Risk Factor for Esophageal Squamous Cell Carcinoma in Japanese Men
    Kenta Watanabe,Sho Fukuda,Dai Kubota,Nobutake Yamamichi, Yu Takahashi, Yoshitaka Watanabe,Kyoichi Adachi,Norihisa Ishimura,Tomoyuki Koike,Hideyuki Sugawara,Kiyotaka Asanuma,Yasuhiko Abe,

    Several case series have noted an association between Barrett’s esophagus (BE) and esophageal squamous cell carcinoma (ESCC). We conducted a nationwide retrospective cohort study to examine the association between baseline BE status, particularly ultra-short-segment BE (USSBE; BE <1 cm), and subsequent ESCC development, focusing on the presence or absence of extensive gastric atrophy (GA). Consecutive male participants who underwent endoscopy at 17 health check-up institutes in Japan between 2013 and 2017 and had follow-up endoscopy by December 2022 were enrolled. Baseline endoscopic images were reviewed to assess GA and BE status. The primary outcome was ESCC development during follow-up. The association between BE status and ESCC was estimated using the Kaplan–Meier method and Cox regression. Among 20,402 male subjects, 7161 (35.1

    2026
    引用
    AI阅读
    加入学术空间
    5NewBeyond Fecal Abundance: Defining the Active Therapeutic Entity in Bifidobacterium-mediated Protection Against Klebsiella-driven MASLD
    Kaan Zıkşahna, Murat Ihlamur
    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 10156 篇论文

    高被引作者

    作者引用发文
    Tooru Shimosegawa957789
    Kamisawa Terumi596337
    Kazuaki Chayama5532101
    Mamoru Watanabe548469
    Kazuhiko Koike501974
    Toshifumi Hibi499184
    Kazuichi Okazaki496070
    Tetsuhide Ito421333
    Hiroto Miwa403054
    Kentaro Sugano402952

    高产作者

    作者引用发文
    Kazuaki Chayama5532101
    Tooru Shimosegawa957789
    Hiromitsu Kumada328288
    Toshifumi Hibi499184
    Yoshikazu Kinoshita347879
    Kazuhiko Koike501974
    Kiwamu Okita258273
    Kazuichi Okazaki496070
    Mamoru Watanabe548469
    Kenji Ikeda255668

    相关期刊

    Scandinavian journal of gastroenterology
    Expert review of gastroenterology & hepatology
    Gut and liver
    Clinical and translational gastroenterology
    Clinics and Research in Hepatology and Gastroenterology
    Gastroenterology report
    Current Opinion in Gastroenterology
    Hepatology Research
    Digestive and Liver Disease
    JHEP REPORTS